Skip to main content

Table 2 Patient characteristics according to hs-TnT levels on inclusion in the study

From: Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI study

  All patients Quartile (Q) 1 to 2 Quartile (Q) 3 to 4 P -value
(n =155) (n =78) (n =77) (Q 1 to 2 versus Q 3 to 4)
hs-TnT, ng/L, range 18-17837 18-415 418-17837 -
Age 63 (56 to 72) 63 (56 to 70) 64 (57 to 72) 0.25
Male sex 132 (85%) 67 (86%) 65 (84%) 0.80
Body mass index 26 (24 to 29) 27 (25 to 29) 26 (24 to 28) 0.054
Creatinine clearance, mL/minute 94 (72 to 126) 100 (77 to 129) 88 (67 to 123) 0.13
Coronary artery disease, n (%) 50 (32%) 26 (33%) 24 (31%) 0.77
Diabetes mellitus, n (%) 33 (21%) 22 (28%) 11 (14%) 0.034
Hypertension, n (%) 70 (45%) 35 (45%) 35 (46%) 0.94
Heart failure, n (%) 23 (15%) 16 (21%) 7 (9%) 0.045
SAPS II score 58 (40 to 69) 54 (37 to 66) 62 (44 to 69) 0.034
Resuscitation     
Witnessed cardiac arrest, n (%) 143 (92%) 73 (94%) 70 (91%) 0.53
Bystander CPR, n (%) 105 (68%) 55 (71%) 50 (65%) 0.46
Time to ROSC, minutes 20 (14 to 29) 17 (11 to 21) 26 (18 to 32) <0.001
Treatment during ICU stay     
Therapeutic hypothermia 134 (87%) 67 (86%) 67 (87%) 0.84
Coronary angiography 34 (22%) 14 (18%) 20 (26%) 0.23
PCI 15 (10%) 2 (3%) 13 (17%) 0.003
Infection     
Pneumonia 64 (41%) 34 (44%) 30 (39%) 0.56
Sepsis 9 (6%) 5 (6%) 4 (5%) 1.00
Outcome     
Mechanical ventilation, h 50 (40 to 79) 49 (40 to 73) 57 (43 to 89) 0.24
ICU LOS, days 3.2 (2.2 to 5.0) 3.1 (2.1 to 5.2) 3.6 (2.3 to 4.9) 0.51
Hospital mortality 45 (29%) 18 (23%) 27 (35%) 0.10
Mortality after 1 year 59 (38%) 22 (28%) 37 (48%) 0.011
CPC 3 to 5 after 1 year 65 (42%) 24 (31%) 41 (53%) 0.005
  1. n, number of patients; hs-TnT, high-sensitivity troponin T; SAPS II, simplified acute physiology score II; SOFA, sequential organ failure assessment score CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; PCI, percutaneous coronary intervention; LOS, length of stay; CPC, cerebral performance categories. Continuous data are presented as median (quartile 1 to 3).